Drug-drug Interaction Study(Lobeglitazone, Warfarin)

NCT02002611 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Lobeglitazone
DRUG: Warfarin

Sponsor

Chong Kun Dang Pharmaceutical